A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.
Clinical trial NCT00436241 · COMPLETED
Trial details
- NCT number
- NCT00436241
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2010-11-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.